These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22177103)

  • 1. Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.
    Tang JY
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S6-9. PubMed ID: 22177103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma.
    Lupi O
    Int J Dermatol; 2007 Nov; 46(11):1113-7. PubMed ID: 17988327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinomas: attack of the hedgehog.
    Epstein EH
    Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehog signaling in basal cell carcinoma.
    Otsuka A; Levesque MP; Dummer R; Kabashima K
    J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling.
    Saran A
    Future Oncol; 2010 Jun; 6(6):1003-14. PubMed ID: 20528237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists.
    Metcalfe C; de Sauvage FJ
    Cancer Res; 2011 Aug; 71(15):5057-61. PubMed ID: 21771911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging treatments and signaling pathway inhibitors.
    Tang JY; Marghoob AA
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of hedgehog signaling pathway inhibitors.
    Liu H; Gu D; Xie J
    Chin J Cancer; 2011 Jan; 30(1):13-26. PubMed ID: 21192841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Basset-Seguin N
    Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS36-VS41. PubMed ID: 30477683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.
    Von Hoff DD; LoRusso PM; Rudin CM; Reddy JC; Yauch RL; Tibes R; Weiss GJ; Borad MJ; Hann CL; Brahmer JR; Mackey HM; Lum BL; Darbonne WC; Marsters JC; de Sauvage FJ; Low JA
    N Engl J Med; 2009 Sep; 361(12):1164-72. PubMed ID: 19726763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinomas in mice overexpressing sonic hedgehog.
    Oro AE; Higgins KM; Hu Z; Bonifas JM; Epstein EH; Scott MP
    Science; 1997 May; 276(5313):817-21. PubMed ID: 9115210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
    Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal cell nevus syndrome: clinical and molecular review and case report.
    Pino LC; Balassiano LK; Sessim M; de Almeida AP; Empinotti VD; Semenovitch I; Treu C; Lupi O
    Int J Dermatol; 2016 Apr; 55(4):367-75. PubMed ID: 26356331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures.
    Brellier F; Bergoglio V; Valin A; Barnay S; Chevallier-Lagente O; Vielh P; Spatz A; Gorry P; Avril MF; Magnaldo T
    Oncogene; 2008 Nov; 27(51):6601-6. PubMed ID: 18679421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of Drug Resistance in Basal Cell Nevus Syndrome Tumors through Basal to Squamous Cell Carcinoma Transition.
    Jussila AR; Haensel D; Gaddam S; Oro AE
    J Invest Dermatol; 2024 Jun; 144(6):1368-1377.e6. PubMed ID: 38157930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?
    Gache Y; Brellier F; Rouanet S; Al-Qaraghuli S; Goncalves-Maia M; Burty-Valin E; Barnay S; Scarzello S; Ruat M; Sevenet N; Avril MF; Magnaldo T
    PLoS One; 2015; 10(12):e0145369. PubMed ID: 26694869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling pathway: a novel target for cancer therapy: vismodegib, a promising therapeutic option in treatment of basal cell carcinomas.
    Abidi A
    Indian J Pharmacol; 2014; 46(1):3-12. PubMed ID: 24550577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
    Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
    Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.